AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15214586
Drug: tibolone 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tibolone 1.25 mg/day
Trial: 3536489
Drug: Cyclizine, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclizine, 50 mg
Trial: 3536489
Drug: Perphenazine, 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perphenazine, 2.5 mg
Trial: 28185407
Drug: Dialysate temperature
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysate temperature at 37°C and sodium concentration at 138 mmol/L (Mode A)
Trial: 28185407
Drug: Dialysate temperature
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysate temperature at 35°C and sodium concentration at 138 mmol/L (Mode B)
Trial: 25049330
Drug: Sequential sunitinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential sunitinib then everolimus
Trial: 19651171
Drug: 100 microg
RxNorm normalized name: Digoxin 100 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 microg non-adjuvanted RSV-A vaccine
Trial: 19651171
Drug: 100 microg
RxNorm normalized name: Digoxin 100 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 microg adjuvanted RSV-A vaccine
Trial: 9854507
Drug: Endogenous/exogenous TNF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endogenous/exogenous TNF therapy (EET) with recombinant TNF‐SAM2 (rTNF‐S) and anti-cancer drugs (mitomycin-C and 5-FU)
Trial: 9854507
Drug: Endogenous/exogenous TNF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endogenous/exogenous TNF therapy (EET) alone
Trial: 2361813
Drug: Fluoxetine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (60 mg daily)
Trial: 2191749
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of prophylactic antibiotics
Trial: 2191749
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of prophylactic antibiotics
Trial: 31618430
Drug: Zinc (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (25 mg) supplementation
Trial: 26096777
Drug: Adapalene 0.1%
RxNorm normalized name: ADAPALENE 0.1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapalene 0.1% and benzoyl peroxide 2.5% gel (A-BPO)
Trial: 15088723
Drug: FM 2/Diafix‐oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FM 2/Diafix‐oral
Trial: 15088723
Drug: FM 2/MPS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FM 2/MPS gel (ceramic)
Trial: 9543160
Drug: Subcutaneous abdominal
RxNorm normalized name: PAD,ABDOMINAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous abdominal fat area
Trial: 25260214
Drug: Present Centered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Present Centered Therapy (PCT)
Trial: 29183930
Drug: Chlorhexidine (0.1%)
RxNorm normalized name: chlorhexidine 0.01 MG/MG
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine (0.1%) solution for meatal cleaning prior to catheter insertion
Trial: 25439116
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care with adjunct intervention (guided imagery/relaxation exercises DVD)
Trial: 23224788
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg aprepitant
Trial: 21332630
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (dutasteride 0.5 mg + tamsulosin 0.4 mg)
Trial: 16988169
Drug: Valdecoxib, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib, 40 mg with a 20-mg redose (n = 127)
Trial: 16988169
Drug: Valdecoxib, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib, 40 mg with a placebo redose (n = 122)
Trial: 16988169
Drug: Valdecoxib, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib, 20 mg twice daily (n = 160)
Trial: 16988169
Drug: Valdecoxib, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib, 20 mg once daily (n = 159)
Trial: 2568838
Drug: bopindolol (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bopindolol (0.05 mg, 0.5 mg, 1 mg, 2 mg)
Trial: 2568838
Drug: nifedipine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nifedipine (2 x 20 mg)
Trial: 27234199
Drug: PTSD treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTSD treatment participation
Trial: 27407018
Drug: Metformin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin treatment for 6 months
Trial: 16648506
Drug: Oral uracil
RxNorm normalized name: uracil
DrugBank: Uracil (DB03419)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral uracil and tegafur (UFT) plus leucovorin (LV)
Trial: 15612616
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of fluconazole 200 mg
Trial: 6195795
Drug: Local chemotherapy
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local chemotherapy (doxorubicin) for carcinoma in situ
Trial: 6195795
Drug: Intravesical chemotherapy
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical chemotherapy after complete transurethral resection of superficial bladder tumors
Trial: 6195795
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy following radical surgery or radiotherapy
Trial: 27874971
Drug: Cefiderocol 1000
RxNorm normalized name: cefiderocol 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefiderocol 1000 mg intravenous infusion
Trial: 18158690
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of vitamin E
Trial: 18158690
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of vitamin C
Trial: 18158690
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of vitamin E and 1000 mg of vitamin C
Trial: 14693597
Drug: rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rocuronium 0.6 mg/kg followed by cisatracurium 0.03 mg/kg
Trial: 14693597
Drug: cisatracurium 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cisatracurium 0.15 mg/kg followed by cisatracurium 0.03 mg/kg
Trial: 14693597
Drug: rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rocuronium 0.6 mg/kg followed by rocuronium 0.15 mg/kg
Trial: 11858491
Drug: Ximelagatran (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ximelagatran (60 mg p.o.)
Trial: 2193712
Drug: Inderal LA
RxNorm normalized name: Inderal LA
DrugBank: Propranolol (DB00571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inderal LA 160 mg daily
Trial: 2193712
Drug: Half-Inderal LA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-Inderal LA 80 mg daily
Trial: 16788808
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (PN)
Trial: 19689921
Drug: Modafinil (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (up to 300 mg/d)
Trial: 15502050
Drug: PTX 5
RxNorm normalized name: PTX-100
DrugBank: PTX-100 (DB18125)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTX 5 mg/kg IV infusion before anesthesia induction
Trial: 28987470
Drug: ω‐3 long
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ω‐3 long chain‐PUFA (2.9 g/day)
Trial: 25693783
Drug: Ixekizumab 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ixekizumab 25 mg
Trial: 25693783
Drug: Ixekizumab 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ixekizumab 75 mg
Trial: 25693783
Drug: Ixekizumab 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ixekizumab 150 mg
Trial: 19077131
Drug: Fluoxetine or
RxNorm normalized name: fluoxetine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine or venlafaxine (n = 30)
Trial: 9440743
Drug: Postoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative adjuvant external-beam radiation therapy (XRT)
Trial: 8206471
Drug: Empiric self-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric self-treatment with clotrimazole 500 mg ovule at the onset of symptoms for 6 months
Trial: 2914540
Drug: Sennosides (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sennosides (30 mg orally at 7:00 PM)
Trial: 4736626
Drug: Stilboestrol 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stilboestrol 7.5 mg daily
Trial: 4736626
Drug: Stilboestrol 15
RxNorm normalized name: Stilboestrol
DrugBank: Diethylstilbestrol (DB00255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stilboestrol 15 mg daily
Trial: 30014661
Drug: Moxibustion combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxibustion combined with 5‐HT receptor antagonist
Trial: 22992074
Drug: Severe hypoglycemia
RxNorm normalized name: acetaminophen / diphenhydramine hydrochloride Oral Tablet [Tylenol Severe Allergy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Severe hypoglycemia without insulin treatment
Trial: 19927026
Drug: Quercetin (Q;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin (Q; 1000 mg x d(‐1))
Trial: 16293869
Drug: Weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel 35 mg/m2 on days 1, 8, and 15 for < or = eight cycles
Trial: 16293869
Drug: 3‐weekly docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3‐weekly docetaxel 75 mg/m2 on day 1 every 3 weeks for < or = eight cycles
Trial: 11916776
Drug: HBOC‐201 (0.6,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBOC‐201 (0.6, 0.9, 1.2, 1.5, 2.0, or 2.5 g/kg of body weight)
Trial: 7639505
Drug: Captopril +
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril + Hydrochlorothiazide (50 mg/25 mg)
Trial: 30033974
Drug: Levofloxacin (LVFX)
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin (LVFX) 500 mg
Trial: 17446716
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral and topical administration of lutein and zeaxanthin
Trial: 17446716
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of zeaxanthin
Trial: 15023936
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 8 mg (C8)
Trial: 15023936
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 16 mg (C16)
Trial: 11772257
Drug: Cilomilast (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilomilast (up to 15 mg)
Trial: 2906863
Drug: Reinforcement for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinforcement for abstinence from illicit drug use
Trial: 31762105
Drug: Intervention (integrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention (integrating smoking cessation treatment into usual AOD treatment)
Trial: 19745765
Drug: Figitumumab (F,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Figitumumab (F, CP-751,871) 0.05-20 mg/kg in combination with paclitaxel 200 mg/m2 and carboplatin (AUC 6) q3 weeks for up to six cycles.
Trial: 19745765
Drug: Figitumumab (F,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Figitumumab (F, CP-751,871) 10 and 20 mg/kg dosing cohorts.
Trial: 12891222
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice (300 mL)
Trial: 11174009
Drug: Captopril (112
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (112 +/- 7 mg/day)
Trial: 11174009
Drug: Doxazosin (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (8 +/- 1 mg/day)
Trial: 9059480
Drug: CPAP at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPAP at 10 cm H2O at a FGF rate of 50 l/min
Trial: 17484092
Drug: Rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 10 mg per day
Trial: 18271912
Drug: Lamotrigine (fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (fixed dose of 50 mg or 200 mg daily in Study 1; flexible dose of 100‐400 mg daily in Study 2; fixed dose of 200 mg daily in Studies 3, 4 and 5)
Trial: 16163899
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg Iclopid tablets (test formulation)
Trial: 6327600
Drug: Low-dose pivmecillinam
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose pivmecillinam for up to three months
Trial: 30290983
Drug: Commercial ultrasound
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercial ultrasound transmission gel (USTG)
Trial: 30290983
Drug: Glucomannan gel
DrugBank: Konjac mannan (DB14963)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucomannan gel
Trial: 24813620
Drug: Lenalidomide 10
RxNorm normalized name: lenalidomide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide 10 mg/d (days 1-21)
Trial: 24813620
Drug: Lenalidomide 5
RxNorm normalized name: lenalidomide 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide 5 mg/d (days 1-28)
Trial: 24813620
Drug: Lenalidomide 5
RxNorm normalized name: lenalidomide 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide 5 mg/d
Trial: 21988705
Drug: Aloe vera/olive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe vera/olive oil cream
Trial: 21988705
Drug: Betamethasone 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone 0.1% cream
Trial: 20152239
Drug: Aged garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged garlic extract plus supplement
Trial: 15707855
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone 100 mg once daily for 72 hours
Trial: 15707855
Drug: IV hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IV hydrocortisone 100 mg every 6 hours for 72 hours
Trial: 7284649
Drug: Phenytoin 300
RxNorm normalized name: phenytoin 300 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin 300 mg per day for two weeks
Trial: 27836430
Drug: Monthly dosing
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly dosing with ranibizumab 0.3 mg every 4 weeks
Trial: 2088768
Drug: Romazarit (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Romazarit (single oral doses ranging from 40 to 1500 mg)
Trial: 2088768
Drug: Placebo (capsules)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (capsules)
Trial: 28644761
Drug: Satir communication
RxNorm normalized name: Vagisil Satin
DrugBank: Hydrocortisone acetate (DB14539)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Satir communication family therapy (CFT), 7 sessions
Trial: 23435190
Drug: Formulation A
RxNorm normalized name: meningococcal vaccine of unknown formulation and unknown serogroups
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation A (0.5% AR-12286 Ophthalmic Solution) once daily, both eyes for 8 days
Trial: 23435190
Drug: Formulation B
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation B (0.5% AR-12286 Ophthalmic Solution) once daily, both eyes for 8 days
Trial: 17627241
Drug: Single 9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 9 mg/kg dose antithymocyte globulin (ATG)
Trial: 17627241
Drug: Two 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two 20 mg doses of basiliximab
Trial: 12738159
Drug: Rectal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal misoprostol 600 microg
Trial: 23464658
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia with propofol and remifentanil (TIVA)
Trial: 19342206
Drug: Zolmitriptan 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan 7.5 mg/d
Trial: 15377579
Drug: Ropivacaine 2
RxNorm normalized name: fentanyl-ropivacaine 2 mcg/mL-0.1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 2 mg ml(‐1) and fentanyl 5 microg ml(‐1) without clonidine (Group RF)
Trial: 9702404
Drug: Intraperitoneal postoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal postoperative treatment
Trial: 22092477
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity laser therapy (LILT) applied with a diode laser (588 nm) before and immediately after surgery, and for 5 min daily for 7 days post-operatively
Trial: 18400982
Drug: Transdermal methylphenidate
RxNorm normalized name: methylphenidate Transdermal System
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal methylphenidate
Trial: 17701685
Drug: Chronotherapeutic strategies
RxNorm normalized name: Other chemotherapeutics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronotherapeutic strategies (timed administration of antihypertensive medication)
Trial: 31693129
Drug: Oral clodronate
RxNorm normalized name: Clodronic acid
DrugBank: Clodronic acid (DB00720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral clodronate
Trial: 12202673
Drug: Intravenous pamidronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pamidronate or zoledronic acid
Trial: 10701819
Drug: Trandolapril 2
RxNorm normalized name: trandolapril 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril 2 mg once daily
Trial: 2283644
Drug: Perindopril 4
RxNorm normalized name: perindopril 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4 mg once daily
Trial: 17084621
Drug: Sequential chemo-radiotherapy
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential chemo-radiotherapy
Trial: 31785830
Drug: Sequential chemo-radiotherapy
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential chemo-radiotherapy (anthracycline-CMF subgroup)
Trial: 16213322
Drug: Calcitriol therapy
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcitriol therapy (group 1, n = 57)
Trial: 12165477
Drug: Anticholinergic drug
RxNorm normalized name: Anticholinergics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticholinergic drug (0.4 mg iv scopolamine)
Trial: 9885795
Drug: ipsapirone (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipsapirone (0.3 mg/kg)
Trial: 2044333
Drug: Flumazenil infusion
RxNorm normalized name: Flumazenil
DrugBank: Flumazenil (DB01205)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flumazenil infusion at 10 micrograms/L
Trial: 21127282
Drug: Midazolam infusion
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam infusion
Trial: 30797389
Drug: Happiness exercises
RxNorm normalized name: Happy Cappy
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Happiness exercises (5 brief self-administered exercises)
Trial: 9492719
Drug: Methylergometrine 0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylergometrine 0.125 mg three times a day for three days
Trial: 23103596
Drug: Tramadol hydrochloride
RxNorm normalized name: Tramadol Hydrochloride
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol hydrochloride 25 mg
Trial: 29221795
Drug: Lidocaine hydrochloride
RxNorm normalized name: Lidocaine Hydrochloride
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine hydrochloride 20 mg
Trial: 28564127
Drug: Terlipressin (1-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (1-4 μg/kg/h) for 5 days
Trial: 10686803
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of lisinopril (32.5-35 mg/daily)
Trial: 10686803
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of lisinopril (2.5-5 mg/daily)
Trial: 1912370
Drug: Bestatin immunotherapy
RxNorm normalized name: Nystatin
DrugBank: Nystatin (DB00646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bestatin immunotherapy
Trial: 31538590
Drug: Placebo (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (400 mg corn oil daily for 180 days)
Trial: 16412747
Drug: Oral estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estrogen therapy (0.625 mg of conjugated equine E per tablet; n = 27)
Trial: 16412747
Drug: Topical estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical estrogen therapy (0.625 mg conjugated equine E per 1 g vaginal cream; n = 30)
Trial: 8546117
Drug: Oral estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estrogen therapy